Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

662 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio.
Vergori A, Tavelli A, Matusali G, Azzini AM, Augello M, Mazzotta V, Pellicanò GF, Costantini A, Cascio A, De Vito A, Marconi L, Righi E, Sartor A, Pinnetti C, Maggi F, Bai F, Lanini S, Piconi S, Levy Hara G, Marchetti G, Giannella M, Tacconelli E, d'Arminio Monforte A, Antinori A, Cozzi-Lepri A, On Behalf Of The Vax-Icona-Orchestra Study. Vergori A, et al. Among authors: costantini a. Vaccines (Basel). 2023 Oct 30;11(11):1664. doi: 10.3390/vaccines11111664. Vaccines (Basel). 2023. PMID: 38005996 Free PMC article.
Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV.
Merlini E, Cozzi-Lepri A, Castagna A, Costantini A, Caputo SL, Carrara S, Quiros-Roldan E, Ursitti MA, Antinori A, D'Arminio Monforte A, Marchetti G. Merlini E, et al. Among authors: costantini a. BMC Infect Dis. 2021 Jun 12;21(1):557. doi: 10.1186/s12879-021-06260-y. BMC Infect Dis. 2021. PMID: 34116650 Free PMC article.
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count.
Marchetti G, Cozzi-Lepri A, Merlini E, Bellistrì GM, Castagna A, Galli M, Verucchi G, Antinori A, Costantini A, Giacometti A, di Caro A, D'arminio Monforte A; ICONA Foundation Study Group. Marchetti G, et al. Among authors: costantini a. AIDS. 2011 Jul 17;25(11):1385-94. doi: 10.1097/QAD.0b013e3283471d10. AIDS. 2011. PMID: 21505312
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting.
d'Arminio Monforte A, Cozzi-Lepri A, Di Biagio A, Marchetti G, Lo Caputo S, Rusconi S, Gianotti N, Mazzotta V, Mazzarello G, Costantini A, Castagna A, Antinori A; ICONA Foundation Study Group. d'Arminio Monforte A, et al. Among authors: costantini a. J Antimicrob Chemother. 2019 May 1;74(5):1363-1367. doi: 10.1093/jac/dky566. J Antimicrob Chemother. 2019. PMID: 30698801
Correction to: Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV.
Merlini E, Cozzi-Lepri A, Castagna A, Costantini A, Caputo SL, Carrara S, Quiros-Roldan E, Ursitti MA, Antinori A, D'Arminio Monforte A, Marchetti G. Merlini E, et al. Among authors: costantini a. BMC Infect Dis. 2021 Jun 24;21(1):603. doi: 10.1186/s12879-021-06330-1. BMC Infect Dis. 2021. PMID: 34167481 Free PMC article. No abstract available.
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting.
d'Arminio Monforte A, Gianotti N, Cozzi-Lepri A, Pinnetti C, Andreoni M, di Perri G, Galli M, Poli A, Costantini A, Orofino G, Maggiolo F, Mazzarello G, Celesia BM, Luciani F, Lazzarin A, Sighinolfi L, Rizzardini G, Bonfanti P, Perno CF, Antinori A; ICONA Foundation Cohort. d'Arminio Monforte A, et al. Among authors: costantini a. Antivir Ther. 2014;19(3):319-24. doi: 10.3851/IMP2687. Epub 2013 Sep 13. Antivir Ther. 2014. PMID: 24036891
Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy.
Di Biagio A, Cozzi-Lepri A, Prinapori R, Angarano G, Gori A, Quirino T, De Luca A, Costantini A, Mussini C, Rizzardini G, Castagna A, Antinori A, dʼArminio Monforte A; ICONA Foundation Study Group. Di Biagio A, et al. Among authors: costantini a. J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):263-71. doi: 10.1097/QAI.0000000000000849. J Acquir Immune Defic Syndr. 2016. PMID: 26871881 Free PMC article.
Polyclonal serum-free light chains elevation in HIV-infected patients.
Bibas M, Lorenzini P, Cozzi-Lepri A, Calcagno A, di Giambenedetto S, Costantini A, Castagna A, Manfrin V, Monforte AD, Antinori A; ICONA Cohort Study Group. Bibas M, et al. Among authors: costantini a. AIDS. 2012 Oct 23;26(16):2107-10. doi: 10.1097/QAD.0b013e328358d54b. AIDS. 2012. PMID: 22874521
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy.
Fabeni L, Santoro MM, Lorenzini P, Rusconi S, Gianotti N, Costantini A, Sarmati L, Antinori A, Ceccherini-Silberstein F, d'Arminio Monforte A, Saracino A, Girardi E, On Behalf Of The Icona Foundation Study Cohort. Fabeni L, et al. Among authors: costantini a. Viruses. 2020 Jul 23;12(8):791. doi: 10.3390/v12080791. Viruses. 2020. PMID: 32718024 Free PMC article.
662 results